Modulation of murine lyme borreliosis by interruption of the B7/CD28 T- cell costimulatory pathway

Infection and Immunity

Volumn 66, Issue 1, 1998, Pages 266-271

  Shanafelt, Marie Claude ^a   Kang, Insoo ^a   Barthold, Stephen W ^a   Bockenstedt, Linda K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; CELL DIFFERENTIATION; DISEASE PREDISPOSITION; GENETIC RESISTANCE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; LYME DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031984907     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.1.266-271.1998     Document Type: Article

References (37)

1. Anguita, J., R. Roth, S. Samanta, R. J. Gee, S. W. Barthold, M. Mamula, and E. Fikrig. 1997. B7-2 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis. Infect. Immun. 65:3037-3041.
2. Barbour, A. G. 1984. Isolation and cultivation of Lymc disease spirochetes. Yale J. Biol. Med. 57:521-525.
3. Barthold, S. W., D. S. Beck, G. M. Hansen, G. A. Terwilliger, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162:133-138.
4. Barthold, S. W., M. S. de Souza, J. L. Janotka, A. L. Smith, and D. H. Persing. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol 43:419-420.
5. Barthold, S. W., S. Feng, L. K. Bockenstedt E. Fikrig, and K. Feen. 1997. Protective and arthritis-resolving activity in serum of mice infected with Borrelia burgdoferi. Clin. Infect. Dis. 25(Suppt. 1):S9-S17.
6. Barthold, S. W., C. L. Sidmaii, and A. L. Smith. 1992. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47:605-613.
7. Bordello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303-313.
8. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Locksley. 1994. Differ ential effects of blockage of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:4142-4148.
9. Fell, H. P., M. A. Gayle, D. Yelton, L. Lipsich, G. L. Schieven, J. S. Marken, A. Aniffo, K. E. Hellstrom, I. Hellstrom, and J. Bajorath. 1992. Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding site. J. Biol. Chem. 267:15552-15558.
10. Finck, B. K., P. S. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science 265:1225-1227.
11. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2costimulatory ligands: expression and function. J. Exp. Med. 180:631-640.
12. Kang, I., S. W. Barthold, D. H. Persing, and L. K. Bockenstedt. 1997. T helper cell cytokines in the early evolution of murine Lyme arthritis. Infect. Immun. 65:3107-3111.
13. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783-788.
14. Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFNλ in modulation of immunity to Borrelia burgdoferi in mice. J. Immunol. 155:2020-2028.
15. Kochi, S. K., R. C. Johnson, and A. P. Dalmasso. 1991. Complementmediated killing of the Lyme disease spirochete Borrelia burgdorferi. J. Immunol. 146:3964-3970.
16. Kochi, S. K., R. C. Johnson, and A. P. Dalmasso. 1993. Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments. Infect. Immun. 61:2532-2536.
17. Kuchruo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
18. Ledbetter, J. A., and L. A. Herzenberg. 1979. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63-90.
19. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145-1155.
20. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
21. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmair, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561-569.
22. Ma, Y., K. P. Seiler, K. Tai, L. Yang, M. Woods, and J. J. Weis. 1994. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production hy the cytokine-inducible pathway. Infect. Immun. 62:3663-3671.
23. Matyniak, J. E., and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181:1251-1254.
24. Montgomery, R. R., and S. E. Malawista. 1994. Borrelia burgdorferi and the macrophage: routine annihilation but occasional haven? Parasitol. Today 10:154-157.
25. Morrison, T. B., J. H. Weis, and J. J. Weis. 1997. Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J. Immunol. 158:4838-4845.
26. Perrin, P. J., J. H. Maldonado, T. A. Davis, C. H. June, and M. K. Racke. 1996. CTLA-4 blockage enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1333-1336.
27. Racke, M. K., D. E. Scott, L. Quigley, G. S. Gray, R. Abe, C. H. June, and P. J. Perrin. 1995. Distinct roles for B7-1 (CD80) and B7-2 (CD86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:2195-2203.
28. Schaible, U., M. Kramer, C. Museteanu, H. Zimmer, H. Mossman, and M. M. Simon. 1989. The severe combined immunodeficient mouse: a laboratory model of Lyme arthritis and carditis. J. Exp. Med. 170:1427-1432.
29. Schaible, U. E., M. D. Kramer, R. Wallich, T. Tran, and M. M. Simon. 1991. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur. J. Immunol. 21:2397-2405.
30. Schmitz, J. L., S. D. Lovrich, S. M. Callister, and R. F. Schell. 1991. Depletion of complement and effects of passive transfer of resistance to infection with Borrelia burgdoferi. Infect. Immun. 59:3815-3818.
31. Sharpe, A. H. 1995. Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice. Curr. Opin. Immunol. 7:389-395.
32. Simon, A. K., E. Seipelt, and J. Sieper. 1994. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 91:8562-8566.
33. Thompson, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979-982.
34. Wallace, P. M., J. S. Johnson, J. F. MacMaster, K. A. Kennedy, P. Gladstone, and P. S. Linsley. 1994. CTLA-4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility complex barriers. Transplantation 58:602-610.
35. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoprolifcrativc disorders with early lethality in mice deficient in CTLA-4. Science 270:985-988.
36. Yang, L., J. H. Weis, E. Eichwald, C. P. Kolbert, D. H. Persing, and J. J. Weis. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62:492-500.
37. Yssel, H., M. D. Shanafelt, C. Sodenberg, R. Schneider, and G. Peltz. 1991. Borrelia burgdorferi activates a T helper type 1-likc T cell subset in Lyme arthritis. J. Exp. Med. 174:593-601.